Feasibility of a Smart-phone Based Support System for Hazardous Drinkers
NCT ID: NCT03553056
Last Updated: 2019-05-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
114 participants
INTERVENTIONAL
2018-04-30
2018-12-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Step Away: Comparing a Chatbot-delivered Alcohol Intervention With a Smartphone App
NCT04447794
A Web App for Patients With Alcohol and Drug Use Problems in Primary Care
NCT01830114
Smartphone Technology: Young Adult Drinking
NCT02963818
Evaluation of an Internet-based Intervention for Hazardous Drinkers
NCT01075685
AAT-APP+: A Novel Brain-training App to Reduce Drinking
NCT04923256
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aims: To 1) adapt the "Step Away' app for New Zealand, then 2) undertake a feasibility study to determine whether six months access to the app can reduce the frequency of alcohol abuse and increase engagement with substance abuse-related health services in adult, hazardous drinkers in Auckland.
Design: Double-blind, randomised-controlled trial.
Recruitment: Community advertising, including social media.
Sample size: As a feasibility study, no sample size calculation was undertaken. However, 200 people (100 in each arm) will provide sufficient data to ascertain the direction and likely effect size for the various alcohol-related outcomes, the likely recruitment rate, and estimates around participant retention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
NZ Step Away app
NZ Step Away app
Access to 10 modules of the app (namely: drinkers profile, goal setting, rewards, cravings, strategies, support, reminders, high risk times, moods, activities)
Control
Modified NZ Step Away app
Modified NZ Step Away app
Access to 2 modules of the app (namely: drinkers profile and goals setting)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NZ Step Away app
Access to 10 modules of the app (namely: drinkers profile, goal setting, rewards, cravings, strategies, support, reminders, high risk times, moods, activities)
Modified NZ Step Away app
Access to 2 modules of the app (namely: drinkers profile and goals setting)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* at least 18 years of age
* have access to a smartphone
* report that they currently drink alcohol
* have had at least two episodes of binge drinking (defined as six or more drinks on one occasion) in the past 30 days
* meet the criteria for hazardous drinking (i.e. 8-19 on the AUDIT)
* express motivation to moderate or abstain from drinking.
Exclusion Criteria
* Currently enrolled in an alcohol programme
* Another person in the household is already a participant.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Waitemata District Health Board
OTHER_GOV
University of Alaska Anchorage
OTHER
University of Auckland, New Zealand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Natalie Walker
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Natalie Walker, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Auckland, New Zealand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institute for Health Innovation, University of Auckland
Auckland, , New Zealand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U1111-1195-2467
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.